- Home
- OPBK vs FENC Comparison
OPBK vs FENC Comparison
Compare OPBK & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPBK
- FENC
- Stock Information
- Founded
- OPBK 2005
- FENC 1996
- Country
- OPBK United States
- FENC United States
- Employees
- OPBK N/A
- FENC N/A
- Industry
- OPBK Major Banks
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OPBK Finance
- FENC Health Care
- Exchange
- OPBK Nasdaq
- FENC Nasdaq
- Market Cap
- OPBK 204.6M
- FENC 225.4M
- IPO Year
- OPBK 2018
- FENC 2001
- Fundamental
- Price
- OPBK $14.54
- FENC $8.92
- Analyst Decision
- OPBK Hold
- FENC Strong Buy
- Analyst Count
- OPBK 1
- FENC 2
- Target Price
- OPBK $15.50
- FENC $13.50
- AVG Volume (30 Days)
- OPBK 44.3K
- FENC 68.3K
- Earning Date
- OPBK 10-23-2025
- FENC 08-14-2025
- Dividend Yield
- OPBK 3.40%
- FENC N/A
- EPS Growth
- OPBK 8.15
- FENC N/A
- EPS
- OPBK 1.48
- FENC N/A
- Revenue
- OPBK $84,078,000.00
- FENC $33,302,000.00
- Revenue This Year
- OPBK $22.05
- FENC $0.96
- Revenue Next Year
- OPBK $10.50
- FENC $51.71
- P/E Ratio
- OPBK $9.54
- FENC N/A
- Revenue Growth
- OPBK 9.17
- FENC N/A
- 52 Week Low
- OPBK $10.43
- FENC $3.96
- 52 Week High
- OPBK $18.57
- FENC $9.42
- Technical
- Relative Strength Index (RSI)
- OPBK 65.13
- FENC 57.95
- Support Level
- OPBK $14.10
- FENC $7.57
- Resistance Level
- OPBK $14.37
- FENC $9.11
- Average True Range (ATR)
- OPBK 0.37
- FENC 0.51
- MACD
- OPBK 0.08
- FENC 0.07
- Stochastic Oscillator
- OPBK 82.23
- FENC 79.56
About OPBK OP Bancorp
OP Bancorp is engaged in the general commercial banking business in Los Angeles, Orange, and Santa Clara Counties, California, Carrollton, Texas, and Las Vegas, Nevada. The Bank is focused on serving the banking needs of small- and medium-sized businesses, professionals, and residents with a particular emphasis on Korean and other ethnic minority communities. It operates with eleven full branches.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.